Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T18:22:37.991Z.
Calculation as of: 2026-10-06T18:22:37.991Z.
Quote observation: 2026-10-06T18:20:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 54b27289092361ea6502e61cba635145b9acb525321868e00b72fceafc9e89d3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$1.71B
Price/FCF Ratio
11.95
TTM Avg
22.90
3Y Avg
20.38
5Y Avg
20.07
Market Cap
$1.72B
Price/FCF Ratio
N/A
TTM Avg
131.77
3Y Avg
73.06
5Y Avg
73.06
Market Cap
$1.74B
Price/FCF Ratio
N/A
TTM Avg
13.58
3Y Avg
13.58
5Y Avg
13.58
Market Cap
$1.76B
Price/FCF Ratio
31.70
TTM Avg
64.78
3Y Avg
64.78
5Y Avg
64.78
Market Cap
$1.77B
Price/FCF Ratio
9.42
TTM Avg
10.13
3Y Avg
16.69
5Y Avg
44.23
Market Cap
$1.64B
Price/FCF Ratio
393.72
TTM Avg
377.27
3Y Avg
377.27
5Y Avg
377.27
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Personalis, Inc. (PSNL) | $1.71B | N/A | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 11.95 | 22.90 | 20.38 | 20.07 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.72B | N/A | 131.77 | 73.06 | 73.06 |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.68B | N/A | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.74B | N/A | 13.58 | 13.58 | 13.58 |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.76B | 31.70 | 64.78 | 64.78 | 64.78 |
| Surgery Partners, Inc. (SGRY)vs › | $1.77B | 9.42 | 10.13 | 16.69 | 44.23 |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.64B | 393.72 | 377.27 | 377.27 | 377.27 |
| Novocure Ltd (NVCR)vs › | $1.78B | N/A | 414.74 | 302.73 | 386.97 |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.63B | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
